always good to dream but
Hunter Hall are not buyers (nor sellers) since no announcements
no-one else has bought a significant stake in the frenzy of the last 3 weeks, suggesting mostly traders not investors
no-one bothered with a takeover when they had a chance. There was a time not so long ago that a 66 cps offer would have been a 100% premium to the share price.
why would GSK spend to buy 7% royalty when they already have 93% for nothing.
remember LANI royalty for ROW will be split with Sankyo, so BTA's share probably won't be much more than 5%: not many double digit royalties out there.
i have no knowledge, page-4
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)